Clinical Trial Update: Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment [NA]

View source ↗

Summary

The document indicates that a clinical study evaluating the 18F-rhPSMA-7.3 radiotracer for diagnosing prostate cancer after focal gland treatment is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-rhPSMA-7.3 (rhPSMA-7.3 radiotracer)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Prostate Cancer | NA | Status: RECRUITING